Cargando…
Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported
OBJECTIVE: This study evaluated the potential efficacy of a novel approach to treat COVID-19 patients, using an oxygen-ozone (O(2)-O(3)) mixture, via a process called Oxygen-Ozone- Immunoceutical Therapy. The methodology met the criteria of a novel, promising approach to treat successfully elderly C...
Autores principales: | Franzini, Marianno, Valdenassi, Luigi, Ricevuti, Giovanni, Chirumbolo, Salvatore, Depfenhart, Markus, Bertossi, Dario, Tirelli, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414302/ https://www.ncbi.nlm.nih.gov/pubmed/32795898 http://dx.doi.org/10.1016/j.intimp.2020.106879 |
Ejemplares similares
-
Male vs. Female Differences in Responding to Oxygen–Ozone Autohemotherapy (O(2)-O(3)-AHT) in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Chirumbolo, Salvatore, et al.
Publicado: (2021) -
The need for a correct oxygen-ozone autohemotherapy (O(3)-AHT) in patients with mild to moderate COVID-19 pneumonia
por: Chirumbolo, Salvatore, et al.
Publicado: (2021) -
Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach
por: Franzini, Marianno, et al.
Publicado: (2022) -
Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Greatly Improved Fatigue Symptoms When Treated with Oxygen-Ozone Autohemotherapy
por: Tirelli, Umberto, et al.
Publicado: (2021) -
The Role of Ozone as an Nrf2-Keap1-ARE Activator in the Anti-Microbial Activity and Immunity Modulation of Infected Wounds
por: Franzini, Marianno, et al.
Publicado: (2023)